Skip to content
MBQ Pharma Logo
  • Home
  • Science
  • Team
  • News
  • Contact

Team

Team

TeamFlamingo Design2024-12-28T14:28:07-04:00

Management

Leadership

José F. Rodríguez-Orengo, PhD

CEO

Leadership

Neil Sankar, MD, MPh

CMO

Leadership

Carlos Dominguez, ME

CFO

Leadership

Carlos Rivera, RQAP-GCP, ASQ CQA-CPGP

Manufacturing and Clinical Quality Lead

Leadership

Scott Houston, BS

Clinical Operations Lead

Scientific Advisory Board

Scientific Advisory Board

Michael Caligiuri, MD, MS

Scientific Advisory Board

Ken Livak, PhD

Scientific Advisory Board

Hope Rugo, MD, FASCO

Scientific Advisory Board

J. Randolph Hecht, MD

MBQ Pharma Logo

Privacy Policy

The USFDA accepted the IND in June 2022 for the lead candidate MBQ-167 for a Phase 1 study in therapeutic-resistant advanced breast cancer.

©   MBQ Pharma • All Rights Reserved • Website by Flamingo Design

Page load link

Let’s Make Things Happen

  • Home
  • Science
  • Team
  • News
  • Contact
Contact Info

41 Avada Avenue, Florida, 98765

403-904-3623

Unlock Your Online GrowthUnlock Your Online Growth
Go to Top